About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

PETACC-8 miR-31-3p and miR-31-5p Ancillary Study

NCT03362684·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

IntegraGen SA

With

Federation Francophone de Cancerologie Digestive
Exystat

Age

18–74

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Patient included in PETACC08 study
Signed informed consent for translational study
FFPE tumor sample available for miR-31-3p and miR-31-5p expression testing

You may not be if

Patient who have withdrawn their consent for PETACC08 and/or for PETACC08 translational study

The record

StatusCompleted

PhasePhase 3

Taking part1,808

StartedNov 2005

UpdatedDec 5, 2017

Conditions

Colorectal Cancer

Clareo Health | PETACC-8 miR-31-3p and miR-31-5p Ancillary Study